Utah Cash from 2010 to 2025

UTMD Stock  USD 59.61  0.14  0.23%   
Utah Medical's Cash is increasing over the years with slightly volatile fluctuation. Overall, Cash is expected to go to about 112.1 M this year. Cash is the total amount of money in the form of currency that Utah Medical Products has in its possession. This includes all bills, coins, and funds in bank accounts. View All Fundamentals
 
Cash  
First Reported
1987-12-31
Previous Quarter
88.5 M
Current Value
83 M
Quarterly Volatility
23.1 M
 
Oil Shock
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Utah Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Utah Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 7.7 M, Interest Expense of 669.3 K or Total Revenue of 36.6 M, as well as many indicators such as Price To Sales Ratio of 3.45, Dividend Yield of 0.0243 or PTB Ratio of 4.36. Utah financial statements analysis is a perfect complement when working with Utah Medical Valuation or Volatility modules.
  
Check out the analysis of Utah Medical Correlation against competitors.

Latest Utah Medical's Cash Growth Pattern

Below is the plot of the Cash of Utah Medical Products over the last few years. Cash refers to the most liquid asset of Utah Medical Products, which is listed under current asset account on Utah Medical Products balance sheet and usually includes currency, coins, checking accounts, and not deposited checks received from Utah Medical customers. The amounts must be unrestricted with restricted cash listed in a different Utah Medical account. It is the total amount of money in the form of currency that a company has in its possession. This includes all bills, coins, and funds in bank accounts. Utah Medical's Cash historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Utah Medical's overall financial position and show how it may be relating to other accounts over time.
Cash10 Years Trend
Slightly volatile
   Cash   
       Timeline  

Utah Cash Regression Statistics

Arithmetic Mean45,867,644
Geometric Mean29,831,634
Coefficient Of Variation77.46
Mean Deviation28,682,350
Median42,787,000
Standard Deviation35,531,092
Sample Variance1262.5T
Range110.4M
R-Value0.97
Mean Square Error80.6T
R-Squared0.94
Slope7,237,312
Total Sum of Squares18936.9T

Utah Cash History

2025112.1 M
2024106.8 M
202392.9 M
202275.1 M
202161 M
202051.6 M
201942.8 M

Other Fundumenentals of Utah Medical Products

Utah Medical Cash component correlations

About Utah Medical Financial Statements

Utah Medical stakeholders use historical fundamental indicators, such as Utah Medical's Cash, to determine how well the company is positioned to perform in the future. Although Utah Medical investors may analyze each financial statement separately, they are all interrelated. For example, changes in Utah Medical's assets and liabilities are reflected in the revenues and expenses on Utah Medical's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Utah Medical Products. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Cash106.8 M112.1 M
Cash And Short Term Investments106.8 M112.1 M
Change In Cash20.5 M21.5 M
Free Cash Flow24.9 M26.1 M
Begin Period Cash Flow86.3 M90.6 M
Other Cashflows From Financing Activities134.6 K141.3 K
Other Non Cash Items-29.7 K-28.2 K
Total Cash From Operating Activities25.6 M26.9 M
Total Cash From Financing Activities-3.7 M-3.9 M
End Period Cash Flow106.8 M112.1 M
Total Cashflows From Investing Activities-736.2 K-773 K
Cash And Cash Equivalents Changes17.1 M17.9 M
Cash Flows Other Operating-12.7 K-12 K
Other Cashflows From Investing Activities-8.1 K-8.5 K
Free Cash Flow Yield 0.08  0.08 
Operating Cash Flow Per Share 5.51  5.79 
Free Cash Flow Per Share 5.36  5.62 
Cash Per Share 22.98  24.13 
Capex To Operating Cash Flow 0.03  0.03 
EV To Operating Cash Flow 11.03  15.87 
EV To Free Cash Flow 11.36  10.79 
Price To Operating Cash Flows Ratio 15.81  16.69 
Price To Free Cash Flows Ratio 16.28  30.70 
Cash Ratio 17.75  18.63 
Cash Conversion Cycle 165.25  104.19 
Operating Cash Flow Sales Ratio 0.40  0.26 
Free Cash Flow Operating Cash Flow Ratio 0.87  0.65 
Cash Flow Coverage Ratios 67.98  71.37 
Price Cash Flow Ratio 15.81  16.69 
Cash Flow To Debt Ratio 67.98  71.37 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Utah Medical Products is a strong investment it is important to analyze Utah Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Utah Medical's future performance. For an informed investment choice regarding Utah Stock, refer to the following important reports:
Check out the analysis of Utah Medical Correlation against competitors.
You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Utah Medical. If investors know Utah will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Utah Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.27)
Dividend Share
1.205
Earnings Share
3.96
Revenue Per Share
11.677
Quarterly Revenue Growth
(0.26)
The market value of Utah Medical Products is measured differently than its book value, which is the value of Utah that is recorded on the company's balance sheet. Investors also form their own opinion of Utah Medical's value that differs from its market value or its book value, called intrinsic value, which is Utah Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Utah Medical's market value can be influenced by many factors that don't directly affect Utah Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Utah Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Utah Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Utah Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.